Correlation of KIT and PDGFRA mutational status with clinical benefit in patients (pts) with gastrointestinal stromal tumor (GIST) treated with sunitinib (SU) in a worldwide treatment-use (TU) trial

Author(s):
Reichardt, P.; Demetri, G.D.; Gelderblom, H.; Rutkowski, P.; ; Gupta, S.; Kang, Y.K.; Schoffski, P.; Schuette, J.; Soulieres, D.; Blay, J.Y.; Goldstein, D.; Fly, K.D.; Huang, X.; Corsaro, M.; Lechuga, M.; Martini, J.F.; Heinrich, M.C.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-05-20
Language
English
Is part of
Journal of Clinical Oncology (2014), No. 15
hdl
1887/105132